CoChat

Probiotic-derived ferrichrome inhibits colon cancer progression via JNK-mediated apoptosis

Open access

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Previous reports have suggested that some probiotics inhibit tumorigenesis and cancer progression. However, the molecules involved have not yet been identified. Here, we show that the culture supernatant of Lactobacillus casei ATCC334 has a strong tumour-suppressive effect on colon cancer cells. Using mass spectrometry, we identify ferrichrome as a tumour-suppressive molecule produced by L. casei ATCC334. The tumour-suppressive effect of ferrichrome is greater than that of cisplatin and 5-fluorouracil, and ferrichrome has less of an effect on non-cancerous intestinal cells than either of those agents. A transcriptome analysis reveals that ferrichrome treatment induces apoptosis, which is mediated by the activation of c-jun N-terminal kinase (JNK). Western blotting indicates that the induction of apoptosis by ferrichrome is reduced by the inhibition of the JNK signalling pathway. This we demonstrate that probiotic-derived ferrichrome exerts a tumour-suppressive effect via the JNK signalling pathway.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms12365

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Conditioned media derived from the Lactobacillus spp. reduced the progression of colon cancer cells. An SRB assay revealed that the numbers of colon cancer cells, Caco2/bbe (a), SKCO-1 (b) and SW620 cells (c), were significantly lower in the conditioned media from the Lactobacillus GG ATCC53103-, L. casei ATCC334-, L. coryniformis ATCC25600- and L. fermentis ATCC23271-treated groups than in the control group. The strongest tumour-suppressive effect against colon cancer cells was observed in the conditioned media from the L. casei ATCC334 group. The error bars show the s.d. (n=5).
Figure 1 Conditioned media derived from the Lactobacillus spp. reduced the progression of colon cancer cells. An SRB assay revealed that the numbers of colon cancer cells, Caco2/bbe (a), SKCO-1 (b) and SW620 cells (c), were significantly lower in the conditioned media from the Lactobacillus GG ATCC53103-, L. casei ATCC334-, L. coryniformis ATCC25600- and L. fermentis ATCC23271-treated groups than in the control group. The strongest tumour-suppressive effect against colon cancer cells was observed in the conditioned media from the L. casei ATCC334 group. The error bars show the s.d. (n=5).CC BY · PubMed Central
Figure 2 The tumour-suppressive effect of low molecular weight fraction from the L. casei ATCC334 culture supernatant. The tumour-suppressive effects of the L. casei ATCC334 culture supernatant fractions were examined after filtration through 3-, 5-, 10-, 30- or 50-kDa membranes (a). The tumour-suppressive fraction was dialyzed using a 0.5 kDa dialysis device (b). A tumour-suppressive effect was confirmed in the fractions that were separated from the L. casei ATCC334 culture supernatant by size-exclusion chromatography (c). The conditioned medium of L. casei was used as a positive control in the following study. The fractions were assessed using reverse-phase chromatography and a tumour-suppressive effect was identified in the 17th fraction by size-exclusion chromatography.
Figure 2 The tumour-suppressive effect of low molecular weight fraction from the L. casei ATCC334 culture supernatant. The tumour-suppressive effects of the L. casei ATCC334 culture supernatant fractions were examined after filtration through 3-, 5-, 10-, 30- or 50-kDa membranes (a). The tumour-suppressive fraction was dialyzed using a 0.5 kDa dialysis device (b). A tumour-suppressive effect was confirmed in the fractions that were separated from the L. casei ATCC334 culture supernatant by size-exclusion chromatography (c). The conditioned medium of L. casei was used as a positive control in the following study. The fractions were assessed using reverse-phase chromatography and a tumour-suppressive effect was identified in the 17th fraction by size-exclusion chromatography.CC BY · PubMed Central
Figure 3 The separation of the tumour-suppressive fraction from the L. casei ATCC334 culture supernatant. (a) The fractions were assessed using DEAE anion-exchange chromatography and a tumour-suppressive effect was identified in the 1st fraction by reverse-phase chromatography (b). The fractions were assessed by CM cation-exchange chromatography and a tumour-suppressive effect was identified in the 2nd fraction by DEAE anion-exchange chromatography (c). The fractions were assessed by SP cation-exchange chromatography and a tumour-suppressive effect was identified from the 6th fraction by CM cation-exchange chromatography (d). The fractions were assessed by ZIC-HILIC chromatography and a tumour-suppressive effect was identified in the 13th fraction by SP cation-exchange chromatography (e). An HPLC chromatogram of the tumour-suppressive fraction. The sample was separated on a Superdex peptide column, eluted with distilled water at a flow rate of 1 ml min−1. The eluent was monitored by ultraviolet spectrophotometry at 210 nm (f). The error bars show the s.d. (n=5).
Figure 3 The separation of the tumour-suppressive fraction from the L. casei ATCC334 culture supernatant. (a) The fractions were assessed using DEAE anion-exchange chromatography and a tumour-suppressive effect was identified in the 1st fraction by reverse-phase chromatography (b). The fractions were assessed by CM cation-exchange chromatography and a tumour-suppressive effect was identified in the 2nd fraction by DEAE anion-exchange chromatography (c). The fractions were assessed by SP cation-exchange chromatography and a tumour-suppressive effect was identified from the 6th fraction by CM cation-exchange chromatography (d). The fractions were assessed by ZIC-HILIC chromatography and a tumour-suppressive effect was identified in the 13th fraction by SP cation-exchange chromatography (e). An HPLC chromatogram of the tumour-suppressive fraction. The sample was separated on a Superdex peptide column, eluted with distilled water at a flow rate of 1 ml min−1. The eluent was monitored by ultraviolet spectrophotometry at 210 nm (f). The error bars show the s.d. (n=5).CC BY · PubMed Central
Figure 4 A tumour-suppressive fraction separated from the culture supernatant of L. casei ATCC334 contained ferrichrome. The mass spectrometry analyses of the tumour-suppressive fraction (a) and ferrichrome (b) are shown. An ESI-Q-TOF analysis indicated that all of the spectrums of the m/z ratio of the fraction (c) corresponded with spectrums of the m/z ratio of ferrichrome (d).
Figure 4 A tumour-suppressive fraction separated from the culture supernatant of L. casei ATCC334 contained ferrichrome. The mass spectrometry analyses of the tumour-suppressive fraction (a) and ferrichrome (b) are shown. An ESI-Q-TOF analysis indicated that all of the spectrums of the m/z ratio of the fraction (c) corresponded with spectrums of the m/z ratio of ferrichrome (d).CC BY · PubMed Central
Figure 5 Ferrichrome exhibited tumour-suppressive effects in colon cancer cells, but not in normal epithelial cells. Ferrichrome reduced cellular progression in a dose-dependent manner in Caco2/bbe (a) and SW620 cells (b). Ferrichrome did not affect the cell growth of IEC-18 cells (c) or the primary cultures of intestinal cells (d). 5-FU and cisplatin reduced the cell growth in SW620 (e) and IEC-18 cells (f). *P<0.05 by Student's t-test. The error bars show the s.d. (n=5).
Figure 5 Ferrichrome exhibited tumour-suppressive effects in colon cancer cells, but not in normal epithelial cells. Ferrichrome reduced cellular progression in a dose-dependent manner in Caco2/bbe (a) and SW620 cells (b). Ferrichrome did not affect the cell growth of IEC-18 cells (c) or the primary cultures of intestinal cells (d). 5-FU and cisplatin reduced the cell growth in SW620 (e) and IEC-18 cells (f). *P<0.05 by Student's t-test. The error bars show the s.d. (n=5).CC BY · PubMed Central
Figure 6 Ferrichrome inhibited tumour progression in a mouse xenograft model. In the xenograft model, the enlargement of the tumours in the ferrichrome (10 μg) group was almost completely suppressed, while the tumours in the control group were enlarged (a). The PBS-treated tumours were heavier than the ferrichrome-treated-tumours (b). *P<0.05 by Student's t-test. The error bars show the s.d. (a, n=16; b, n=10).
Figure 6 Ferrichrome inhibited tumour progression in a mouse xenograft model. In the xenograft model, the enlargement of the tumours in the ferrichrome (10 μg) group was almost completely suppressed, while the tumours in the control group were enlarged (a). The PBS-treated tumours were heavier than the ferrichrome-treated-tumours (b). *P<0.05 by Student's t-test. The error bars show the s.d. (a, n=16; b, n=10).CC BY · PubMed Central
Figure 7 Ferrichrome-induced apoptosis is mediated by the ER stress-responsive-JNK pathway. The expression levels of cleaved caspase-3 and PARP in SW620 cells were increased by ferrichrome treatment in a dose-dependent manner (a). TUNEL-positive cells in SW620 cells were increased by ferrichrome treatment (0.1 μg ml−1). The photographs were taken under a high-power view (× 200) (b). DDIT3 expression was assessed using a quantitative RT–PCR (c) and western blotting (d). DDIT3 was found to be highly induced (in a dose-dependent manner) in ferrichrome-treated SW620 cells. A western blotting analysis revealed the activation of the JNK signal transduction pathway in ferrichrome-treated (0.1 μg ml−1) SW620 cells (e). The tumour-suppressive effect was reduced by the inhibition of JNK activation (f). A Western blotting analysis showed the elimination of cleaved caspase-3 and the induction of PARP in ferrichrome-treated (0.1 μg ml−1) SW620 cells by the treatment of SP600125 (g) or siRNA of JNK (h). *P<0.05 by Student's t-test. The error bars show the s.d. (a–e and g, n=3; f, n=5). The original unprocessed scans of the Western blots are shown in Supplementary Fig. 2.
Figure 7 Ferrichrome-induced apoptosis is mediated by the ER stress-responsive-JNK pathway. The expression levels of cleaved caspase-3 and PARP in SW620 cells were increased by ferrichrome treatment in a dose-dependent manner (a). TUNEL-positive cells in SW620 cells were increased by ferrichrome treatment (0.1 μg ml−1). The photographs were taken under a high-power view (× 200) (b). DDIT3 expression was assessed using a quantitative RT–PCR (c) and western blotting (d). DDIT3 was found to be highly induced (in a dose-dependent manner) in ferrichrome-treated SW620 cells. A western blotting analysis revealed the activation of the JNK signal transduction pathway in ferrichrome-treated (0.1 μg ml−1) SW620 cells (e). The tumour-suppressive effect was reduced by the inhibition of JNK activation (f). A Western blotting analysis showed the elimination of cleaved caspase-3 and the induction of PARP in ferrichrome-treated (0.1 μg ml−1) SW620 cells by the treatment of SP600125 (g) or siRNA of JNK (h). *P<0.05 by Student's t-test. The error bars show the s.d. (a–e and g, n=3; f, n=5). The original unprocessed scans of the Western blots are shown in Supplementary Fig. 2.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

Items 201–286 of 286

Metadata

Authors
Konishi, H., Fujiya, M., Tanaka, H., Ueno, N., Moriichi, K., Sasajima, J., Ikuta, K., Akutsu, H., Tanabe, H., & Kohgo, Y.
Affiliations
  • Asahikawa Medical University (JP)
  • International University of Health and Welfare Hospital (JP)
Corresponding author
Fujiya, Mikihiro
Venue
Nature Communications
Published
2016-08-10
Volume
7
Issue
1
Pages
12365-12365
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2491844534
Cited by
287
References
20
Citations by year
2026: 15 · 2025: 36 · 2024: 38 · 2023: 39 · 2022: 35 · 2021: 51 · 2020: 28 · 2019: 19 · 2018: 9 · 2017: 16 · 2016: 1
FWCI
18.90
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Ministry of Health, Labour and Welfare (26460956)
  • Japan Society for the Promotion of Science (26460956, 25460923, 16H06607)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
Keywords
ferrichrome, probiotics, Lactobacillus casei, colon cancer, apoptosis, JNK signaling, c-Jun N-terminal kinase, tumor suppression, culture supernatant, anticancer activity, gene expression profiling
MeSH terms
Animals, Antineoplastic Agents, Cell Survival, Cisplatin, Colon, Colonic Neoplasms, Ferrichrome, Fluorouracil, Humans, Lacticaseibacillus casei, Male, Mice, Inbred BALB C, Mice, Nude, Mass Spectrometry, Up-Regulation, Treatment Outcome, Apoptosis, Disease Progression, Probiotics, Gene Expression Profiling, MAP Kinase Signaling System, Cell Line, Tumor, JNK Mitogen-Activated Protein Kinases, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.